Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation. The NDA has also been granted Priority Review. A Priority Review ...
2009 NOV 23 ... transcriptase polymerase chain reaction (QR-PCR) and defined as no detection of BCR-ABL mRNA. The frequencies of complete and partial cytogenetic response were 29% (n = 34) and ...
2009 NOV 25 ... their financial goals," Greig said. "We are also excited about adding First Bank's ABL business which will allow us to expand our lending effort even further in the Midwest ...
2009 NOV 23 ... treated with a medicine that specifically targets the abnormal protein, known as Bcr-Abl, which causes this leukemia. Today, Kareem continues to live a very full life and is ...
2009 NOV 23 ... 300 cGy total body irradiation (TBI, day-1), and 100 X 10(6) T-cell-depleted ACI (RT1A(abl)) bone marrow cells were transplanted oil day 0, followed by a 11-day course of ...
2009 NOV 16 ... According to a study from the United States, "The c-abl proto-oncogene encodes a nonreceptor tyrosine kinase involved in many cellular ...
2009 NOV 23 ... tyrosine kinase inhibitor therapy was associated with poorer therapeutic responses and ABL tyrosine kinase domain point mutations. In leukemia cell lines, PRAME protein expression ...
2009 NOV 23 ... with isolated ribosomes that were phosphorylated in vitro by kinases PKA, PKC delta, or Abl Tyr showed up to 30% inhibition due to phosphorylation," wrote J.L. Miller and ...
2009 NOV 23 ... defined by the acquired genetic mutation, t(9;22), which leads to the fusion-protein BCR-ABL. Prior to the development of imatinib mesylate (Gleevec), treatment was limited and ...
2009 NOV 23 ... and synaptic pruning that culminates in cytoskeletal stabilization in adulthood. The Abl-related gene (Arg) acts through p190RhoGAP to inhibit the RhoA GTPase and stabilize ...
2009 NOV 23 ... major side effects of chemotherapy in young patients with cancer. Here we describe the c-Abl-TAp63 pathway activated by chemotherapeutic DNA-damaging drugs in model human cell lines ...
2009 NOV 23 ... "Cytogenetic examination showed 46XY, t(9;22)(q34;q11.2) in all of 30 metaphases. BCR-ABL PCR was positive for an e14a2 transcript. He was included in the HOVON-51 study ...
2009 NOV 25 ... borrowings under its senior secured asset-based revolving credit facility (the "ABL facility") to the extent of the value of the collateral securing such guarantee ...
2009 NOV 25 ... senior unsecured indebtedness, pay or prepay outstanding borrowings under its ABL facility and for general corporate purposes.In connection with the ...
